Vaccine News and Research

Latest Vaccine News and Research

IOM report: Few health problems are clearly associated with vaccines

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines.

26 Aug 2011

Hospitals in Libyan capital in urgent need of supplies, medications, MSF says

"Conditions in Tripoli's hospitals could become catastrophic without a rapid improvement in security in the Libyan capital, the emergency coordinator of aid group Medecins Sans Frontieres (MSF) told Reuters on Wednesday."

26 Aug 2011

As Rick Perry moves to front of GOP presidential pack, his health policies trigger speculation

Talk is picking up regarding what exactly 'Perrycare' might look like and how much the nation's health care system will factor into his campaign messages.

26 Aug 2011

Injecting mosquitoes with bacterium shows potential for dengue elimination, scientists report

Injecting mosquitoes with the Wolbachia bacterium "can block them from transmitting the dengue virus and help control the spread of a disease that kills 20,000 annually in more than 100 countries," a team led by Scott O'Neill, a geneticist at the University of Queensland in Brisbane, reports in two papers published in Nature on Thursday, Reuters reports.

26 Aug 2011

Researchers develop single vaccines to prevent rabies, Ebola infection

Researchers from Thomas Jefferson University, among other institutions, including the National Institute of Allergy and Infectious Diseases, have developed single vaccines to protect against both rabies and the Ebola virus.

26 Aug 2011

Emergent announces results of adjuvanted BioThrax anthrax vaccine Phase 1a trial

Emergent BioSolutions Inc. announced today that results from a Phase 1a clinical trial evaluating an investigational anthrax vaccine, Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant mixed at bedside, have been published in Vaccine, a leading medical journal on vaccines and immunology.

26 Aug 2011

IOM issues new report on evidence and causality of vaccine harms

The Institute of Medicine's Panel on Adverse Effects of Vaccines issued a report today on the evidence and causality of vaccine harms. Despite a glowing press release, the report does little to allay public concerns over adverse effects of vaccines and suggests that we urgently need more science on vaccine adverse effects.

26 Aug 2011

Roundup: Federal appeals court says Ariz. Medicaid co-pays violate law; Mich. court rules against medicinal marijuana policies

A federal appeals court ruled Wednesday that mandatory copayments charged to Arizona's poorest residents violate federal law. The three-judge panel of the 9th U.S. Circuit Court of Appeals said federal health officials failed to show how the copays, imposed in November after a seven-year court battle, served any purpose besides cutting the state's Medicaid budget.

26 Aug 2011

Dengue fever mosquito trial successful

Researchers have stopped mosquitoes from spreading the dengue virus by infecting it with bacteria from flies that commonly live in kitchen fruit bowls. The two papers showed how the fruit-fly bacteria was established in wild mosquito populations, offering a practical and inexpensive way to stop transmission of dengue fever which affects 50 million people annually.

25 Aug 2011

Insight into how bacterial toxins cause human diseases may help improve treatment

A better understanding of how bacterial toxins cause common human diseases may lead to their improved treatment and prevention according to a paper just published by Irish and US scientists in Nature Reviews Microbiology.

25 Aug 2011

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.

25 Aug 2011

Study finds novel small molecule that inhibits EboV entry into host cells

Ebola virus (EboV) is the cause of sporadic outbreaks of highly fatal infections in Africa that are unpredictable in onset and rapid in progression. There is no effective vaccine or therapy for EboV infection.

25 Aug 2011

Scientists identify cellular protein that plays a critical role in Ebola virus infection

Research published by two teams of Army scientists and collaborators has identified a cellular protein that plays a critical role in Ebola virus infection.

25 Aug 2011

Some fear industry interests are stalling negotiations on U.N. NCD summit, BMJ reports

"In the run up to the U.N. summit on non-communicable diseases (NCDs), there are fears that industry interests might be trumping evidence-based public health interventions," BMJ reports.

25 Aug 2011

Scientists identify critical protein responsible for Ebola virus infection

In separate papers published online in Nature, two research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.

25 Aug 2011

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

NanoBio Corporation announced today that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus (RSV) vaccine have been published in PLoS One, an international peer-reviewed online publication.

25 Aug 2011

Researchers trace source of latest cholera pandemic

Researchers have used next generation sequencing to trace the source and explain the spread of the latest (seventh) cholera pandemic. They have also highlighted the impact of the acquisition of resistance to antibiotics on shaping outbreaks and show resistance was first acquired around 1982.

25 Aug 2011

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

Although outbreaks are rare, Ebola virus, the cause of Ebola hemorrhagic fever (EHF), is one of the deadliest known viruses affecting humans. According to the World Health Organization (WHO), approximately 1,850 EHF cases with more than 1,200 deaths have been documented since the virus was identified in 1976.

25 Aug 2011

Measles exposure in Philadelphia and Lancaster counties

The Pennsylvania Department of Health and the Philadelphia Department of Public Health are advising the public of exposure to a case of measles in Lancaster and Philadelphia counties.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

Vaccine News and Research

Latest Vaccine News and Research

IOM report: Few health problems are clearly associated with vaccines

Hospitals in Libyan capital in urgent need of supplies, medications, MSF says

As Rick Perry moves to front of GOP presidential pack, his health policies trigger speculation

Injecting mosquitoes with bacterium shows potential for dengue elimination, scientists report

Researchers develop single vaccines to prevent rabies, Ebola infection

Emergent announces results of adjuvanted BioThrax anthrax vaccine Phase 1a trial

IOM issues new report on evidence and causality of vaccine harms

Roundup: Federal appeals court says Ariz. Medicaid co-pays violate law; Mich. court rules against medicinal marijuana policies

Dengue fever mosquito trial successful

Insight into how bacterial toxins cause human diseases may help improve treatment

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

Study finds novel small molecule that inhibits EboV entry into host cells

Scientists identify cellular protein that plays a critical role in Ebola virus infection

Some fear industry interests are stalling negotiations on U.N. NCD summit, BMJ reports

Scientists identify critical protein responsible for Ebola virus infection

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

Researchers trace source of latest cholera pandemic

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

Measles exposure in Philadelphia and Lancaster counties

Research may help explain why live attenuated influenza vaccine elicits protection

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in